Khanna, D., Seibold, J., Goldin, J., Tashkin, D. P., Furst, D. E., & Wells, A. (2017). Interstitial lung disease points to consider for clinical trials in systemic sclerosis. Rheumatology (Oxford).
Chicago Style CitationKhanna, Dinesh, James Seibold, Jonathan Goldin, Donald P. Tashkin, Daniel E. Furst, i Athol Wells. "Interstitial Lung Disease Points to Consider for Clinical Trials in Systemic Sclerosis." Rheumatology (Oxford) 2017.
Cita MLAKhanna, Dinesh, et al. "Interstitial Lung Disease Points to Consider for Clinical Trials in Systemic Sclerosis." Rheumatology (Oxford) 2017.
Atenció: Aquestes cites poden no estar 100% correctes.